Does the media refer more to IRTC or PEN?

In the previous week, iRhythm Technologies had 6 more articles in the media than Penumbra. MarketBeat recorded 7 mentions for iRhythm Technologies and 1 mentions for Penumbra. Penumbra's average media sentiment score of 0.25 beat iRhythm Technologies' score of 0.15 indicating that Penumbra is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment iRhythm Technologies 1 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Penumbra 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer BAX or IRTC?

In the previous week, Baxter International had 11 more articles in the media than iRhythm Technologies. MarketBeat recorded 18 mentions for Baxter International and 7 mentions for iRhythm Technologies. iRhythm Technologies' average media sentiment score of 0.15 beat Baxter International's score of -0.13 indicating that iRhythm Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Baxter International 3 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral iRhythm Technologies 1 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has better earnings & valuation, IRTC or SNN?

Smith & Nephew SNATS has higher revenue and earnings than iRhythm Technologies. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio iRhythm Technologies $747.14M 4.87 -$44.55M -$0.43 N/A Smith & Nephew SNATS $6.16B 1.79 $625M N/A N/A

Does the media refer more to IRTC or SNN?

In the previous week, iRhythm Technologies had 4 more articles in the media than Smith & Nephew SNATS. MarketBeat recorded 7 mentions for iRhythm Technologies and 3 mentions for Smith & Nephew SNATS. iRhythm Technologies' average media sentiment score of 0.15 beat Smith & Nephew SNATS's score of -0.01 indicating that iRhythm Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment iRhythm Technologies 1 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Smith & Nephew SNATS 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral

Does the media favor IRTC or GMED?

In the previous week, iRhythm Technologies had 2 more articles in the media than Globus Medical. MarketBeat recorded 7 mentions for iRhythm Technologies and 5 mentions for Globus Medical. iRhythm Technologies' average media sentiment score of 0.15 beat Globus Medical's score of 0.10 indicating that iRhythm Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment iRhythm Technologies 1 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Globus Medical 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer IRTC or PODD?

In the previous week, Insulet had 2 more articles in the media than iRhythm Technologies. MarketBeat recorded 9 mentions for Insulet and 7 mentions for iRhythm Technologies. Insulet's average media sentiment score of 0.33 beat iRhythm Technologies' score of 0.15 indicating that Insulet is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment iRhythm Technologies 1 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Insulet 1 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

iRhythm Technologies (IRTC) Competitors

$110.37 -0.68 (-0.61%)

Closing price 04:00 PM Eastern

Extended Trading

$110.40 +0.03 (+0.03%)

As of 07:50 PM Eastern

Compare

IRTC vs. PEN, BAX, SNN, GMED, and PODD

Should you buy iRhythm Technologies stock or one of its competitors? iRhythm Technologies's main competitors and comparable companies include Penumbra (PEN), Baxter International (BAX), Smith & Nephew SNATS (SNN), Globus Medical (GMED), and Insulet (PODD). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does iRhythm Technologies compare to Penumbra?

iRhythm Technologies (NASDAQ:IRTC) and Penumbra (NYSE:PEN) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, risk, earnings, media sentiment, dividends and valuation.

iRhythm Technologies has a beta of 1.45, meaning that its share price is 45% more volatile than the broader market. Comparatively, Penumbra has a beta of 0.7, meaning that its share price is 30% less volatile than the broader market.

Penumbra has a net margin of 10.67% compared to iRhythm Technologies' net margin of -1.69%. Penumbra's return on equity of 10.50% beat iRhythm Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
iRhythm Technologies	-1.69%	10.11%	1.53%
Penumbra	10.67%	10.50%	8.17%

88.9% of Penumbra shares are held by institutional investors. 1.0% of iRhythm Technologies shares are held by company insiders. Comparatively, 2.9% of Penumbra shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, iRhythm Technologies had 6 more articles in the media than Penumbra. MarketBeat recorded 7 mentions for iRhythm Technologies and 1 mentions for Penumbra. Penumbra's average media sentiment score of 0.25 beat iRhythm Technologies' score of 0.15 indicating that Penumbra is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
iRhythm Technologies	1 Very Positive mention(s)	0 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Penumbra	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Penumbra has higher revenue and earnings than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iRhythm Technologies	$747.14M	4.87	-$44.55M	-$0.43	N/A
Penumbra	$1.40B	8.93	$177.69M	$4.07	78.15

iRhythm Technologies currently has a consensus target price of $179.93, indicating a potential upside of 62.92%. Penumbra has a consensus target price of $367.07, indicating a potential upside of 15.41%. Given iRhythm Technologies' stronger consensus rating and higher probable upside, equities analysts plainly believe iRhythm Technologies is more favorable than Penumbra.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iRhythm Technologies	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	2 Strong Buy rating(s)	2.94
Penumbra	0 Sell rating(s)	14 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.18

Summary

Penumbra beats iRhythm Technologies on 11 of the 17 factors compared between the two stocks.

How does iRhythm Technologies compare to Baxter International?

Baxter International (NYSE:BAX) and iRhythm Technologies (NASDAQ:IRTC) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, analyst recommendations, profitability, earnings, risk, institutional ownership, dividends and valuation.

Baxter International currently has a consensus price target of $22.45, indicating a potential downside of 4.83%. iRhythm Technologies has a consensus price target of $179.93, indicating a potential upside of 62.92%. Given iRhythm Technologies' stronger consensus rating and higher possible upside, analysts clearly believe iRhythm Technologies is more favorable than Baxter International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Baxter International	2 Sell rating(s)	9 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.00
iRhythm Technologies	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	2 Strong Buy rating(s)	2.94

In the previous week, Baxter International had 11 more articles in the media than iRhythm Technologies. MarketBeat recorded 18 mentions for Baxter International and 7 mentions for iRhythm Technologies. iRhythm Technologies' average media sentiment score of 0.15 beat Baxter International's score of -0.13 indicating that iRhythm Technologies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Baxter International	3 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
iRhythm Technologies	1 Very Positive mention(s)	0 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

iRhythm Technologies has lower revenue, but higher earnings than Baxter International. iRhythm Technologies is trading at a lower price-to-earnings ratio than Baxter International, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Baxter International	$11.24B	1.08	-$957M	-$2.07	N/A
iRhythm Technologies	$747.14M	4.87	-$44.55M	-$0.43	N/A

iRhythm Technologies has a net margin of -1.69% compared to Baxter International's net margin of -9.27%. Baxter International's return on equity of 16.57% beat iRhythm Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Baxter International	-9.27%	16.57%	5.24%
iRhythm Technologies	-1.69%	10.11%	1.53%

90.2% of Baxter International shares are held by institutional investors. 0.2% of Baxter International shares are held by insiders. Comparatively, 1.0% of iRhythm Technologies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Baxter International has a beta of 0.66, suggesting that its share price is 34% less volatile than the broader market. Comparatively, iRhythm Technologies has a beta of 1.45, suggesting that its share price is 45% more volatile than the broader market.

Summary

iRhythm Technologies beats Baxter International on 11 of the 17 factors compared between the two stocks.

How does iRhythm Technologies compare to Smith & Nephew SNATS?

iRhythm Technologies (NASDAQ:IRTC) and Smith & Nephew SNATS (NYSE:SNN) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, valuation, risk, earnings and media sentiment.

25.6% of Smith & Nephew SNATS shares are owned by institutional investors. 1.0% of iRhythm Technologies shares are owned by company insiders. Comparatively, 1.0% of Smith & Nephew SNATS shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Smith & Nephew SNATS has a net margin of 0.00% compared to iRhythm Technologies' net margin of -1.69%. iRhythm Technologies' return on equity of 10.11% beat Smith & Nephew SNATS's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
iRhythm Technologies	-1.69%	10.11%	1.53%
Smith & Nephew SNATS	N/A	N/A	N/A

iRhythm Technologies has a beta of 1.45, indicating that its share price is 45% more volatile than the broader market. Comparatively, Smith & Nephew SNATS has a beta of 0.53, indicating that its share price is 47% less volatile than the broader market.

Smith & Nephew SNATS has higher revenue and earnings than iRhythm Technologies.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iRhythm Technologies	$747.14M	4.87	-$44.55M	-$0.43	N/A
Smith & Nephew SNATS	$6.16B	1.79	$625M	N/A	N/A

In the previous week, iRhythm Technologies had 4 more articles in the media than Smith & Nephew SNATS. MarketBeat recorded 7 mentions for iRhythm Technologies and 3 mentions for Smith & Nephew SNATS. iRhythm Technologies' average media sentiment score of 0.15 beat Smith & Nephew SNATS's score of -0.01 indicating that iRhythm Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
iRhythm Technologies	1 Very Positive mention(s)	0 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Smith & Nephew SNATS	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral

iRhythm Technologies presently has a consensus target price of $179.93, suggesting a potential upside of 62.92%. Smith & Nephew SNATS has a consensus target price of $31.91, suggesting a potential upside of 21.17%. Given iRhythm Technologies' stronger consensus rating and higher probable upside, research analysts plainly believe iRhythm Technologies is more favorable than Smith & Nephew SNATS.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iRhythm Technologies	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	2 Strong Buy rating(s)	2.94
Smith & Nephew SNATS	1 Sell rating(s)	10 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

iRhythm Technologies beats Smith & Nephew SNATS on 10 of the 15 factors compared between the two stocks.

How does iRhythm Technologies compare to Globus Medical?

iRhythm Technologies (NASDAQ:IRTC) and Globus Medical (NYSE:GMED) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, media sentiment, profitability, valuation, institutional ownership, dividends, risk and analyst recommendations.

95.2% of Globus Medical shares are held by institutional investors. 1.0% of iRhythm Technologies shares are held by company insiders. Comparatively, 18.4% of Globus Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Globus Medical has higher revenue and earnings than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than Globus Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iRhythm Technologies	$747.14M	4.87	-$44.55M	-$0.43	N/A
Globus Medical	$2.94B	3.47	$537.87M	$3.91	19.43

In the previous week, iRhythm Technologies had 2 more articles in the media than Globus Medical. MarketBeat recorded 7 mentions for iRhythm Technologies and 5 mentions for Globus Medical. iRhythm Technologies' average media sentiment score of 0.15 beat Globus Medical's score of 0.10 indicating that iRhythm Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
iRhythm Technologies	1 Very Positive mention(s)	0 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Globus Medical	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

iRhythm Technologies has a beta of 1.45, meaning that its stock price is 45% more volatile than the broader market. Comparatively, Globus Medical has a beta of 0.96, meaning that its stock price is 4% less volatile than the broader market.

Globus Medical has a net margin of 17.02% compared to iRhythm Technologies' net margin of -1.69%. Globus Medical's return on equity of 14.57% beat iRhythm Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
iRhythm Technologies	-1.69%	10.11%	1.53%
Globus Medical	17.02%	14.57%	12.62%

iRhythm Technologies currently has a consensus target price of $179.93, suggesting a potential upside of 62.92%. Globus Medical has a consensus target price of $99.46, suggesting a potential upside of 30.92%. Given iRhythm Technologies' stronger consensus rating and higher probable upside, analysts plainly believe iRhythm Technologies is more favorable than Globus Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iRhythm Technologies	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	2 Strong Buy rating(s)	2.94
Globus Medical	0 Sell rating(s)	5 Hold rating(s)	9 Buy rating(s)	3 Strong Buy rating(s)	2.88

Summary

Globus Medical beats iRhythm Technologies on 10 of the 17 factors compared between the two stocks.

How does iRhythm Technologies compare to Insulet?

iRhythm Technologies (NASDAQ:IRTC) and Insulet (NASDAQ:PODD) are both mid-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, media sentiment, risk, institutional ownership, dividends, profitability, valuation and analyst recommendations.

iRhythm Technologies currently has a consensus price target of $179.93, suggesting a potential upside of 62.92%. Insulet has a consensus price target of $195.40, suggesting a potential upside of 49.41%. Given iRhythm Technologies' stronger consensus rating and higher possible upside, equities analysts plainly believe iRhythm Technologies is more favorable than Insulet.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iRhythm Technologies	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	2 Strong Buy rating(s)	2.94
Insulet	2 Sell rating(s)	11 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.42

In the previous week, Insulet had 2 more articles in the media than iRhythm Technologies. MarketBeat recorded 9 mentions for Insulet and 7 mentions for iRhythm Technologies. Insulet's average media sentiment score of 0.33 beat iRhythm Technologies' score of 0.15 indicating that Insulet is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
iRhythm Technologies	1 Very Positive mention(s)	0 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Insulet	1 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

iRhythm Technologies has a beta of 1.45, suggesting that its share price is 45% more volatile than the broader market. Comparatively, Insulet has a beta of 1.11, suggesting that its share price is 11% more volatile than the broader market.

Insulet has higher revenue and earnings than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than Insulet, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iRhythm Technologies	$747.14M	4.87	-$44.55M	-$0.43	N/A
Insulet	$2.71B	3.35	$247.10M	$5.35	24.44

Insulet has a net margin of 12.29% compared to iRhythm Technologies' net margin of -1.69%. Insulet's return on equity of 29.29% beat iRhythm Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
iRhythm Technologies	-1.69%	10.11%	1.53%
Insulet	12.29%	29.29%	13.31%

Summary

Insulet beats iRhythm Technologies on 10 of the 15 factors compared between the two stocks.

Get iRhythm Technologies News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IRTC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

IRTC vs. The Competition

Export

Metric	iRhythm Technologies	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$3.66B	$5.36B	$7.09B	$13.24B
Dividend Yield	N/A	1.80%	2.53%	15.89%
P/E Ratio	241.41	24.66	274.61	26.05
Price / Sales	4.87	41.72	600.51	90.03
Price / Cash	N/A	32.68	77.38	51.25
Price / Book	23.28	5.68	10.92	6.31
Net Income	-$44.55M	$152.11M	$3.50B	$361.43M
7 Day Performance	-0.01%	-2.01%	-2.11%	-1.67%
1 Month Performance	-9.89%	-5.42%	-6.34%	-3.94%
1 Year Performance	-36.50%	2.75%	8.81%	2.77%

iRhythm Technologies Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
IRTC iRhythm Technologies	3.4495 of 5 stars	$110.37 -0.6%	$179.93 +63.0%	-33.7%	$3.66B	$747.14M	N/A	2,400	News Coverage
PEN Penumbra	2.7738 of 5 stars	$319.08 -0.2%	$367.07 +15.0%	+27.5%	$12.59B	$1.40B	78.40	4,700
BAX Baxter International	1.1112 of 5 stars	$23.39 -0.4%	$22.45 -4.0%	+1.2%	$12.14B	$11.24B	N/A	37,500	Analyst Revision
SNN Smith & Nephew SNATS	3.5756 of 5 stars	$26.92 +0.9%	$31.91 +18.5%	-27.9%	$11.20B	$6.16B	N/A	16,988
GMED Globus Medical	4.0957 of 5 stars	$74.56 +0.4%	$101.77 +36.5%	+26.9%	$9.97B	$2.94B	19.07	6,000	Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:IRTC) was last updated on 10/2/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

iRhythm Technologies (IRTC) Competitors

IRTC vs. PEN, BAX, SNN, GMED, and PODD

How does iRhythm Technologies compare to Penumbra?

Summary

How does iRhythm Technologies compare to Baxter International?

Summary

How does iRhythm Technologies compare to Smith & Nephew SNATS?

Summary

How does iRhythm Technologies compare to Globus Medical?

Summary

How does iRhythm Technologies compare to Insulet?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

IRTC vs. The Competition

iRhythm Technologies Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

iRhythm Technologies (IRTC) Competitors

IRTC vs. PEN, BAX, SNN, GMED, and PODD

How does iRhythm Technologies compare to Penumbra?

Which has more volatility and risk, IRTC or PEN?

Is IRTC or PEN more profitable?

Do insiders and institutionals believe in IRTC or PEN?

Does the media refer more to IRTC or PEN?

Which has stronger valuation and earnings, IRTC or PEN?

Do analysts rate IRTC or PEN?

Summary

How does iRhythm Technologies compare to Baxter International?

Do analysts rate BAX or IRTC?

Does the media prefer BAX or IRTC?

Which has better valuation and earnings, BAX or IRTC?

Is BAX or IRTC more profitable?

Do insiders & institutionals believe in BAX or IRTC?

Which has more risk and volatility, BAX or IRTC?

Summary

How does iRhythm Technologies compare to Smith & Nephew SNATS?

Do insiders and institutionals hold more shares of IRTC or SNN?

Is IRTC or SNN more profitable?

Which has more risk & volatility, IRTC or SNN?

Which has better earnings & valuation, IRTC or SNN?

Does the media refer more to IRTC or SNN?

Do analysts rate IRTC or SNN?

Summary

How does iRhythm Technologies compare to Globus Medical?

Do insiders & institutionals have more ownership in IRTC or GMED?

Which has higher valuation and earnings, IRTC or GMED?

Does the media favor IRTC or GMED?

Which has more volatility and risk, IRTC or GMED?

Is IRTC or GMED more profitable?

Do analysts prefer IRTC or GMED?

Summary

How does iRhythm Technologies compare to Insulet?

Do analysts rate IRTC or PODD?

Does the media prefer IRTC or PODD?

Which has more risk and volatility, IRTC or PODD?

Which has stronger valuation and earnings, IRTC or PODD?

Is IRTC or PODD more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

IRTC vs. The Competition

iRhythm Technologies Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools